Outsourced Pharma White Papers

1. Molecular Properties Of PROTACs And The Relationship To Formulation Design 3/4/2025

   Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.

2. Antibody-Drug Conjugates – Catalysts For Chemistry 5/16/2024

   Review the complexities of developing linkers – chemical moieties which attach a drug payload to an antibody – and considerations when identifying a CRO for ADC research and development.

3. Nose To Brain (N2B) Drug Delivery – Benefits And Challenges 11/20/2024

   Delve into the growing interest in drug delivery methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).

4. Preparing For Disease X: Effective Vaccine Development In The Face Of A Future Pandemic 5/8/2024

   CDMOs are playing a critical role in the global effort to prepare for future pandemics. Learn how innovative strategies and flexible platforms are helping to ensure a swift and effective response plan.

5. Next-Generation CRISPR Approaches 7/16/2024

   By providing essential components like nucleases, gRNAs, and HDR templates, a reliable CDMO facilitates a seamless transition from discovery research to clinical trials and beyond.

6. Optimizing Reference Standards For Your Biopharmaceutical 1/29/2024

   By addressing considerations for a comprehensive reference standard strategy, manufacturers can ensure the integrity of biopharmaceuticals, ultimately paving the way for better patient outcomes.

7. The Critical Role Of Comparative Analytical Assessments 4/25/2024

   Utilizing expert analytical testing services can unlock the potential of biosimilars and bring cost-effective treatments to market faster.

8. Quantitation Of Monoclonal Antibodies In Serum 2/8/2024

   Monoclonal antibodies (mAbs) are a rapidly growing group of targeted therapeutics. Gain insight into the importance of optimized bioanalytical assay platforms for mAb development.

9. Advanced Methodology Of PLGA-Based Parenteral Formulations 5/7/2025

   To enable the development of optimized PLGA-based sustained release formulations, this paper offers essential insights into the polymer’s properties, fabrication techniques, and drug release mechanisms.

10. Simplify CAPA In 7 Steps 9/20/2024

    Discover how to streamline corrective action/preventive action (CAPA) management in regulatory environments in 7 steps.